Status:
UNKNOWN
Compassion Program for Parkinson
Lead Sponsor:
Neuromed IRCCS
Conditions:
Parkinson Disease
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Parkinson's disease (PD) is a chronic and progressive neurodegenerative disease of the central nervous system. Second only to Alzheimer's in incidence on the population, Parkinson's disease has a nega...
Detailed Description
Non-motor symptoms in Parkinson's disease are classified in sensory, autonomic, behavioral, cognitive, sleep and psychic disorders. The most frequently presented neuropsychiatric symptoms are anxiety,...
Eligibility Criteria
Inclusion
- PD diagnosis according to UK Parkinson's Disease Society Brain Bank Clinical Diagnostic Criteria (UKPDS)
- Ability to provide written informed consent
- Age between 18 and 80 years (inclusive)
Exclusion
- cognitive impairment
- Inability to provide written informed consent
- any cardiological condition/drugs that alter the heartbeat
- Diagnosis of other concomitant neurodegenerative disease or psychiatric diaseases
Key Trial Info
Start Date :
July 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2023
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05410769
Start Date
July 1 2022
End Date
May 1 2023
Last Update
June 8 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.